GT Biopharma Inc. Common Stock

GTBP XNAS • PHARMACEUTICAL PREPARATIONS

Historical Short Interest Share

American Express® Business Gold Card

Earn Up to 200K Membership Rewards® Points

4X on your top 2 spending categories. Transfer to 20+ airline & hotel partners. Terms apply.

Learn More

Market Cap

17M

Short interest (May 15)

5.8%

Net Short (Jun 03 ): 0.2%

Borrow Fee

4.70%

↓ 22.1%

Available Shares

600K

↑ 37.6%

Price Chart

Company Overview

GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. The company is engaged in discovering, developing, and commercializing therapeutics from its proprietary product platform across various disease areas, mainly focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platform offers immuno-oncology products designed to treat hematologic malignancies, sarcoma, and solid tumors.

Company Info

Exchange: NASDAQ

Industry: PHARMACEUTICAL PREPARATIONS

CIK: 0000109657

Asset Type: CS

Market Data

Market Cap: $16,848,588

Employees: 1

Status: Active

Short Interest

Current Borrow Fee 4.70%

Range: 4.70% - 4.76%

Available Shares 600K

Range: 450K - 750K

Recent Changes

Fee Change: ↓ 4.1%

Available Change: ↓ 16.7%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime